| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
137,858,000 |
| Market
Cap: |
849.21(M) |
| Last
Volume: |
3,159,761 |
Avg
Vol: |
1,451,479 |
| 52
Week Range: |
$6.16 - $6.16 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Achison engages only in internet advertising through www.dazhong368.com in the New York area.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Vitullo Nicole |
Director |
– • – |
2017-08-10 |
4 |
OE |
$3.11 |
$8,750,000 |
I/I |
2,811,245 |
37,885 |
|
- |
|
| Fisherman Jason S |
Director |
– • – |
2017-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,500 |
1,500 |
|
- |
|
| Fisherman Jason S |
Director |
– • – |
2016-12-22 |
4 |
B |
$3.96 |
$39,600 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| Fenton Mary Kay |
Chief Financial Officer |
• – – |
2016-12-05 |
4 |
B |
$4.11 |
$10,275 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
| Barrish Joel C |
Chief Scientific Officer |
• – – |
2016-12-02 |
4 |
B |
$4.06 |
$10,150 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
| Deshpande Milind |
Chief Executive Officer |
• • – |
2016-12-02 |
4 |
B |
$4.06 |
$10,150 |
D/D |
2,500 |
2,500 |
2.81 |
- |
|
| Manning Martha E |
EVP, General Counsel |
• – – |
2016-12-02 |
4 |
B |
$4.09 |
$10,225 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
| Truitt Joseph |
Chief Commercial Officer |
• – – |
2016-12-02 |
4 |
B |
$4.06 |
$14,210 |
D/D |
3,500 |
3,500 |
2.74 |
- |
|
| Apelian David |
Chief Medical Officer |
• – – |
2015-12-30 |
4 |
S |
$10.50 |
$105,000 |
D/D |
(10,000) |
0 |
|
- |
|
| Apelian David |
Chief Medical Officer |
• – – |
2015-12-30 |
4 |
OE |
$3.02 |
$30,200 |
D/D |
10,000 |
10,000 |
|
- |
|
| Fenton Mary Kay |
Chief Financial Officer |
• – – |
2015-12-28 |
4 |
S |
$10.08 |
$438,480 |
D/D |
(43,500) |
0 |
|
- |
|
| Fenton Mary Kay |
Chief Financial Officer |
• – – |
2015-12-28 |
4 |
OE |
$1.05 |
$45,675 |
D/D |
43,500 |
43,500 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-11-11 |
4 |
S |
$10.31 |
$515,500 |
I/I |
(50,000) |
17,179 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-11-10 |
4 |
S |
$10.43 |
$1,867,742 |
I/I |
(179,074) |
17,549 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-11-09 |
4 |
S |
$10.01 |
$3,212,469 |
I/I |
(320,926) |
18,874 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-09-25 |
4 |
S |
$8.22 |
$76,528 |
I/I |
(9,310) |
21,249 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
31,431 |
31,431 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-08-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(483,521) |
0 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-08-14 |
4 |
S |
$7.51 |
$284,201 |
I/I |
(37,843) |
21,318 |
|
- |
|
| Johnson & Johnson Development Corp Et Al |
10% Owner |
– – • |
2015-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,367,346 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
222,630 |
483,521 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2015-05-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,700,000) |
2,872,968 |
|
- |
|
| Fenton Mary Kay |
EVP and CFO |
• – – |
2015-01-23 |
4 |
S |
$16.00 |
$210,000 |
D/D |
(13,125) |
0 |
|
- |
|
| Fenton Mary Kay |
EVP and CFO |
• – – |
2015-01-23 |
4 |
OE |
$4.00 |
$52,500 |
D/D |
13,125 |
13,125 |
|
- |
|
| Deshpande Milind |
President and CEO |
• • – |
2015-01-21 |
4 |
S |
$15.00 |
$1,500,000 |
D/D |
(100,000) |
0 |
|
- |
|
95 Records found
|
|
Page 2 of 4 |
|
|
